Keros Therapeutics (KROS)'s 30-day implied volatility (IV30) was 50.4% at the close on October 20, 2026, down from 52.2% the day before, against a 52-week range of 34.0% to 87.9%. Its 20-day historical volatility was 52.4%.
Data as of October 20, 2026.